Browse medicines, page 8 of 9
Some records contain detailed evidence; others currently contain only basic identity and regulatory information. Reviewed conclusions appear only when they are available for a specific use and group of people.
Showing 421–480 of 526 records
Pegfilgrastim-Fpgk (Stimufend)
Protein medicineApproved in the United States (FDA)Expanded recordPegfilgrastim-Jmdb (Fulphila)
Protein medicineApproved in the United States (FDA)Expanded recordPegfilgrastim-Unne (Armlupeg)
Protein medicineApproved in the United States (FDA)Expanded recordPegloticase (Krystexxa)
Protein medicineApproved in the United States (FDA)Expanded recordUse listed on the medicine record
Chronic gout
Pegunigalsidase alfa (Elfabrio)
Protein medicineLaboratory or animal-stage researchExpanded recordUse listed on the medicine record
Confirmed Fabry disease
Pegunigalsidase Alfa-Iwxj (Elfabrio)
Protein medicineApproved in the United States (FDA)Expanded recordPegzilarginase (Loargys)
Protein medicineLaboratory or animal-stage researchExpanded recordUse listed on the medicine record
Hyperargininemia
Pivekimab Sunirine-Pvzy (Decnupaz)
Protein medicineApproved in the United States (FDA)Expanded recordPlasma Protein Fraction (Octaplas)
Protein medicineLaboratory or animal-stage researchExpanded recordPolatuzumab Vedotin (Polivy)
Protein medicineLaboratory or animal-stage researchExpanded recordUse listed on the medicine record
Relapsed or refractory DLBCL, NOS, after at least two prior therapies
Polatuzumab Vedotin-Piiq (Polivy)
Protein medicineApproved in the United States (FDA)Expanded recordPoractant alfa (Curosurf)
Protein medicineApproved in the United States (FDA)Expanded recordUse listed on the medicine record
The rescue treatment of Respiratory Distress Syndrome (RDS) in premature infants
Pozelimab-Bbfg (Veopoz)
Protein medicineApproved in the United States (FDA)Expanded recordRasburicase (Elitek)
Protein medicineApproved in the United States (FDA)Expanded recordUse listed on the medicine record
The initial management of plasma uric acid levels
Ravulizumab-Cwvz (Ultomiris)
Protein medicineApproved in the United States (FDA)Expanded recordRelatlimab-Rmbw (Opdualag)
Protein medicineApproved in the United States (FDA)Expanded recordReteplase (Retavase)
Protein medicineApproved in the United States (FDA)Expanded recordRomosozumab-Aqqg (Evenity)
Protein medicineApproved in the United States (FDA)Expanded recordRubella Virus Strain Wistar Ra 27/3 Live Antigen (M-M-R II / Proquad)
Protein medicineLaboratory or animal-stage researchExpanded recordSacituzumab Govitecan-Hziy (Trodelvy)
Protein medicineApproved in the United States (FDA)Expanded recordSalmonella Typhi Ty2 VI Polysaccharide Antigen (Typhim VI)
Protein medicineLaboratory or animal-stage researchExpanded recordSargramostim (Leukine)
Protein medicineApproved in the United States (FDA)Expanded recordUse listed on the medicine record
LEUKINE is a leukocyte growth factor indicated: To shorten time to neutrophil recovery and to reduce the incidence of severe and life-threatening infections and infections resulting in death following induction chemotherapy in adult patients 55 years and older with acute myeloid leukemia (AML). ( 1.1 ) For the mobilization of hematopoietic progenitor cells into peripheral blood for collection by leukapheresis and autologous transplantation in adult patients.
Sibeprenlimab-Szsi (Voyxact)
Protein medicineApproved in the United States (FDA)Expanded recordSomatropin [rdna Origin] (Nutropin)
Protein medicineApproved in the United States (FDA)Expanded recordStreptococcus Pneumoniae Type 10a Capsular Polysaccharide Antigen (Pneumovax 23)
Protein medicineLaboratory or animal-stage researchExpanded recordStreptococcus Pneumoniae Type 14 Capsular Polysaccharide Antigen (Pneumovax 23)
Protein medicineLaboratory or animal-stage researchExpanded recordStreptococcus Pneumoniae Type 14 Capsular Polysaccharide Diphtheria Crm197 Protein Conjugate Antigen (Vaxneuvance / Prevnar 13 / Prevnar 20)
Protein medicineLaboratory or animal-stage researchExpanded recordStreptococcus Pneumoniae Type 17f Capsular Polysaccharide Antigen (Pneumovax 23)
Protein medicineLaboratory or animal-stage researchExpanded recordStreptococcus Pneumoniae Type 18c Capsular Polysaccharide Diphtheria Crm197 Protein Conjugate Antigen (Vaxneuvance / Prevnar 13 / Prevnar 20)
Protein medicineLaboratory or animal-stage researchExpanded recordStreptococcus Pneumoniae Type 20 Capsular Polysaccharide Antigen (Pneumovax 23)
Protein medicineLaboratory or animal-stage researchExpanded recordStreptococcus Pneumoniae Type 23f Capsular Polysaccharide Antigen (Pneumovax 23)
Protein medicineLaboratory or animal-stage researchExpanded recordStreptococcus Pneumoniae Type 23f Capsular Polysaccharide Diphtheria Crm197 Protein Conjugate Antigen (Vaxneuvance / Prevnar 13 / Prevnar 20)
Protein medicineLaboratory or animal-stage researchExpanded recordStreptococcus Pneumoniae Type 33f Capsular Polysaccharide Antigen (Pneumovax 23)
Protein medicineLaboratory or animal-stage researchExpanded recordStreptococcus Pneumoniae Type 3 Capsular Polysaccharide Antigen (Pneumovax 23)
Protein medicineLaboratory or animal-stage researchExpanded recordStreptococcus Pneumoniae Type 4 Capsular Polysaccharide Diphtheria Crm197 Protein Conjugate Antigen (Vaxneuvance / Prevnar 13 / Prevnar 20)
Protein medicineLaboratory or animal-stage researchExpanded recordStreptococcus Pneumoniae Type 5 Capsular Polysaccharide Antigen (Pneumovax 23)
Protein medicineLaboratory or animal-stage researchExpanded recordStreptococcus Pneumoniae Type 6a Capsular Polysaccharide Diphtheria Crm197 Protein Conjugate Antigen (Vaxneuvance / Capvaxive / Prevnar 13 / Prevnar 20)
Protein medicineLaboratory or animal-stage researchExpanded recordStreptococcus Pneumoniae Type 6b Capsular Polysaccharide Antigen (Pneumovax 23)
Protein medicineLaboratory or animal-stage researchExpanded recordStreptococcus Pneumoniae Type 6b Capsular Polysaccharide Diphtheria Crm197 Protein Conjugate Antigen (Vaxneuvance / Prevnar 13 / Prevnar 20)
Protein medicineLaboratory or animal-stage researchExpanded recordStreptococcus Pneumoniae Type 7f Capsular Polysaccharide Antigen (Pneumovax 23)
Protein medicineLaboratory or animal-stage researchExpanded recordStreptococcus Pneumoniae Type 9n Capsular Polysaccharide Antigen (Pneumovax 23)
Protein medicineLaboratory or animal-stage researchExpanded recordStreptococcus Pneumoniae Type 9v Capsular Polysaccharide Antigen (Pneumovax 23)
Protein medicineLaboratory or animal-stage researchExpanded recordTagraxofusp (Elzonris)
Protein medicineLaboratory or animal-stage researchExpanded recordUse listed on the medicine record
Blastic plasmacytoid dendritic cell neoplasm
Tagraxofusp-Erzs (Elzonris)
Protein medicineApproved in the United States (FDA)Expanded recordTarlatamab-Dlle (Imdelltra)
Protein medicineApproved in the United States (FDA)Expanded recordUse listed on the medicine record
Extensive stage small cell lung cancer (ES-SCLC) with disease progression on or after platinum-based chemotherapy
Tebentafusp (Kimmtrak)
Protein medicineLaboratory or animal-stage researchExpanded recordUse listed on the medicine record
HLA-A*02
Tebentafusp-Tebn (Kimmtrak)
Protein medicineApproved in the United States (FDA)Expanded recordTeclistamab-Cqyv (Tecvayli)
Protein medicineApproved in the United States (FDA)Expanded recordTisotumab Vedotin (Tivdak)
Protein medicineLaboratory or animal-stage researchExpanded recordUse listed on the medicine record
Recurrent or metastatic cervical cancer with disease progression on or after chemotherapy
Tisotumab Vedotin-Tftv (Tivdak)
Protein medicineApproved in the United States (FDA)Expanded recordTrastuzumab Deruxtecan (Enhertu)
Protein medicineLaboratory or animal-stage researchExpanded recordUse listed on the medicine record
Unresectable or metastatic HER2-positive (IHC 3+ or ISH+) breast cancer who have received a prior anti-HER2-based regime
Trastuzumab-Pkrb (Herzuma)
Protein medicineApproved in the United States (FDA)Expanded recordUrokinase (Kinlytic)
Protein medicineApproved in the United States (FDA)Expanded recordUstekinumab-Aauz (Otulfi)
Protein medicineApproved in the United States (FDA)Expanded recordVaccinia Virus Modified Strain Ankara-Bavarian Nordic Non-Replicating Antigen (Jynneos)
Protein medicineLaboratory or animal-stage researchExpanded recordVelaglucerase alfa (Vpriv)
Protein medicineApproved in the United States (FDA)Expanded recordUse listed on the medicine record
Long-term enzyme replacement therapy
Vestronidase alfa (Mepsevii)
Protein medicineLaboratory or animal-stage researchExpanded recordUse listed on the medicine record
Mucopolysaccharidosis VII
Nogapendekin alfa Inbakicept-Pmln (Anktiva)
Protein medicineApproved in the United States (FDA)Expanded recordUse listed on the medicine record
BCG-unresponsive nonmuscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS) with or without papillary tumors
Peginterferon Beta-1a (Plegridy)
Protein medicineApproved in the United States (FDA)Expanded recordUse listed on the medicine record
PLEGRIDY is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. PLEGRIDY is an interferon beta indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults ( 1 )
Pegzilarginase-Nbln (Loargys)
Protein medicineApproved in the United States (FDA)Expanded record